Marksans Pharma’s arm gets marketing authorization for four products

02 Jul 2024 Evaluate

Marksans Pharma’s wholly owned subsidiary – Relonchem has received marketing authorization from UKMHRA for Rasagiline Relonchem 1 mg Tablets, Olmesartan 10 mg Film-coated Tablets, Olmesartan 20 mg Film-coated Tablets and Olmesartan 40 mg Film-coated Tablets. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

308.55 -0.45 (-0.15%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.